Dr. Nina Niu Sanford (@NiuSanford) “How do we define the role of SBRT in HCC amidst many other available local modal” — TopicDigg
Dr. Nina Niu Sanford
@NiuSanford
GI Radiation Oncologist | Boston, @Princeton, @harvardmed, now @UTSWNews in Dallas | clinical trials | buying in bulk | Tweets=own | FCOI:
加入 November 2018
1.9K 正在关注 10.2K 粉丝
How do we define the role of SBRT in HCC amidst many other available local modalities? Do we need a Ph III RCT with OS endpoint?
Thoughts from @ldawsonmd, liver SBRT pioneer now s/p after decades of experience leading HCC trials.
显示更多
